Infinity Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Infinity Pharmaceuticals

28/03/2023 22:19

* Infinity Pharmaceuticals Inc  INFI.OQ  reported a
quarterly
adjusted loss of 11 cents​​ per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for a loss of 3 cents per share.
    * Revenue rose 20.4% to $543.00 thousand from a year ago;
analysts
expected $600.00 thousand. 
    * Infinity Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 11 cents​.
    * The mean earnings estimate of analysts had risen by
about 39.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Infinity Pharmaceuticals Inc shares had fallen by 67.0%
this
quarter.
    * The company reported a quarterly loss of $9.23 million.
    * Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $4.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 09:19 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.03          -0.11          Missed
 Sep. 30 2022      -0.06          -0.12          Missed
 Jun. 30 2022      -0.15          -0.13          Beat
 Mar. 31 2022      -0.13          -0.14          Missed